Skip to Content
🌐Ship toSelect country

Saypha Volume Plus Lidocaine - 1 x 1,0ml

Saypha Volume Plus Lidocaine is Croma-Pharma's most highly cross-linked, highest-viscosity filler in the Saypha range, indicated for facial tissue augmentation to correct mid-face volume deficit, facial volume restoration and contouring, and reconstructive purposes such as HIV-related facial lipoatrophy. Injected into the deep dermis, subcutaneous or supraperiosteal plane, with an estimated 12-month duration in the skin. For use by licensed, trained medical professionals only.

57.00 € 57.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Saypha
SKU A4805 Share
Treatment Areas CheeksChinFace
Tags Cross-Linked Hyaluronic AcidHyaluronic AcidLidocaineVolumizer

Saypha Volume Plus is a high-viscosity cross-linked hyaluronic acid filler formulated for facial volumising and contouring in areas such as the cheeks and chin. Part of the Saypha range from Croma-Pharma, an Austrian manufacturer with over four decades of experience in hyaluronic acid production for the aesthetics market. Its firm, cohesive gel is designed to restore lost volume and provide structural support, pre-mixed with lidocaine for injection comfort.

CONCENTRATION

  • Cross-linked hyaluronic acid, high viscosity (Croma-Pharma)
  • Lidocaine hydrochloride

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 12-15 months.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Chin volumising

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Saypha Volume Plus is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin